Participants taking semaglutide demonstrated a 26% reduction in the composite endpoint of heart attack, stroke, or cardiovascular death compared to placeboindependent outcomes that correlate with improved lipid profiles
Pollution, UV exposure, even emotional stress
announced that its data from the 48-week IMPACT Phase 2b clinical trial on pemvidutide for treating metabolic dysfunction-associated steatohepatitis (MASH) will be presented at the EASL Congress 2026 in Barcelona
doi: 10.1002/ana.21600
Understanding genetic predispositions helps providers identify whether a lower BMI individual is likely to achieve meaningful metabolic gains or primarily behavioral improvements
An analysis of the transcriptomic profile of RILI in non-human primates revealed that the expression of SERPINA3, ATP12A, GJB2, CLDN10, TOX3, and LPA was significantly up-regulated, suggesting their potential as biomarkers and therapeutic targets for RILI [103]